Chargement en cours...
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
BACKGROUND: Current pharmacological therapies for COPD improve quality of life and symptoms and reduce exacerbations. Given the progressive nature of COPD, it is arguably more important to understand whether the available therapies are able to delay clinical deterioration; the concept of “clinically...
Enregistré dans:
| Publié dans: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6400232/ https://ncbi.nlm.nih.gov/pubmed/30880943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S196383 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|